Novo Nordisk picks AstraZeneca executive to head biopharma business

Novo Nordisk (NOVOb.CO) has hired AstraZeneca's (AZN.L) head of cardiovascular and metabolic diseases to head its biopharma business, which has been struggling with declining sales and a failed acquisition.